2nd Quarter - Report
TODD STRATEGY GROUP for ASTRAZENECA PHARMACEUTICALS LP
Firm
Income
$80,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pediatric Priority Review Voucher Program. General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Global supply chain and investment issues. Prescription drug pricing policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC BERGREN | — |
| KATHERINE FLEMING COTTON | — |
| PAUL EDATTEL | — |
| NICOLAS MAGALLANES | — |
| DANIEL M TODD | — |
Medicare/Medicaid MMM
340B Program. Home Infusion for Part B Products. S.864: HELP Copays Act. Medicare Reimbursement for New Technologies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC BERGREN | Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker |
| KATHERINE FLEMING COTTON | Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie |
| PAUL EDATTEL | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg |
| NICOLAS MAGALLANES | Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander |
| DANIEL M TODD | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.